Immunoengineering: a credible mechanism for CAMPATH-1H action in bone marrow and organ transplantation and the implications for treatment of the immune dysfunction AIDS.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Medical Hypotheses

• Publication date

  2003-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0306-9877(02)00404-8PMID 12581613
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The use of a monoclonal I-J-specific antibody to distinguish cells in the feedback suppression circuit from those in the contrasuppressor circuit

  2004cited by this paper
• Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre

  2001cited by this paper
• Should physicians withhold highly active antiretroviral therapies from HIV-AIDS patients who are thought to be poorly adherent to treatment?

  2001cited by this paper
• Cytomegalovirus seroconversion as a cofactor for progression to AIDS

  2001cited by this paper
• In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.

  2000cited by this paper
• Immune control of HIV-1 after early treatment of acute infection

  2000cited by this paper
• Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.

  2000cited by this paper
• The beneficial effect of donor-specific transfusions: a review of existing explanations and a new hypothesis based on a relatively unapplied theory of T cell immunoregulation. A regulatory hypothesis in progress...

  2000cited by this paper
• AIDSVAX® (MN) in Bangkok Injecting Drug Users: A Report on Safety and Immunogenicity, Including Macrophage-Tropic Virus Neutralization

  2000cited by this paper
• Challenges in the development of an effective HIV vaccine: current approaches and future directions.

  2000cited by this paper
• Boosting Immunity to HIV--Can the Virus Help?

  2000cited by this paper
• Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection.

  1999cited by this paper
• Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients.

  1999cited by this paper
• HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy.

  1999cited by this paper
• HIV-protease inhibitors.

  1998cited by this paper
• Cross-clade T cell recognition of HIV.1.

  1998cited by this paper
• Viral strategies of immune evasion.

  1998cited by this paper
• A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

  1998cited by this paper
• Antigen presentation and related immunological aspects of HIV-1 vaccines.

  1998cited by this paper
• Regulation of apoptosis by viral gene products

  1997cited by this paper
• HIV-1 protease inhibitors. A review for clinicians.

  1997cited by this paper
• Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a cooperative clinical trials in transplantation pilot study. Cooperative Clinical Trials in Transplantation Research Group.

  1997cited by this paper
• HIV‐1 and the thymus

  1997cited by this paper
• Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a Cooperative Clinical Trials in Transplantation pilot study.

  1997cited by this paper
• Potential factors affecting adherence with HIV therapy

  1997cited by this paper
• The cat and mouse games that genes, viruses, and cells play.

  1997cited by this paper
• HIV-1 protease inhibitors. A review for clinicians.

  1997cited by this paper
• Virus-lymphoid cell interactions.

  1996cited by this paper
• Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.

  1996cited by this paper
• One step ahead of the game: viral immunomodulatory molecules.

  1996cited by this paper
• HIV protease inhibitors

  1996cited by this paper
• Introduction: Pathogenesis of persistent virus infections

  1994cited by this paper
• IN VITRO ALLOREACTIVITY AGAINST HOST ANTIGENS IN AN ADULT HLA‐MISMATCHED BONE MARROW TRANSPLANT RECIPIENT DESPITE IN VIVO HOST TOLERANCE

  1993cited by this paper
• HIV-1 protease inhibitors

  1992cited by this paper
• Is immune oversuppression the direct cause of AIDS?

  1990cited by this paper
• T cells recognizing polysaccharide-specific B cells function as contrasuppressor cells in the generation of T cell immunity to Pseudomonas aeruginosa.

  1988cited by this paper
• Mechanisms of persistence in human virus infections.

  1988cited by this paper
• Is cytomegalovirus a cofactor in the pathogenesis of AIDS and Kaposi's sarcoma?

  1986cited by this paper
• Requirements for activation of contrasuppressor T cells by type III pneumococcal polysaccharide.

  1986cited by this paper
• Is cytomegalovirus a cofactor in the pathogenesis of AIDS and Kaposi's sarcoma?

  1986cited by this paper
• Separation and characterization of a subset of human T8+ cells which function as antigen-presenting and contrasuppressor cells.

  1985cited by this paper
• Infection in immunocompromised patients.

  1985cited by this paper
• Viral infections in immunosuppressed patients.

  1984cited by this paper
• Contrasuppression: the second law of thymodynamics, revisited.

  1984cited by this paper
• Suppressor cells and immunoregulation.

  1984cited by this paper
• Immunoregulatory T-cell pathways.

  1983cited by this paper
• Immunoregulatory circuits which modulate responsiveness to suppressor cell signals: contrasuppressor cells can convert an in vivo tolerogenic signal into an immunogenic one

  1981cited by this paper
• Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis.

  1981cited by this paper
• Immunoregulatory circuits that modulate responsiveness to suppressor cell signal. Failure of B10 mice to respond to suppressor factors can be overcome by quenching the contrasuppressor circuit

  1981cited by this paper
• Mechanisms of immunosuppression in cytomegaloviral mononucleosis.

  1980cited by this paper
• The effects of viral infections on renal transplants and their recipients.

  1980cited by this paper
• Increased pulmonary superinfections in cardiac-transplant patients undergoing primary cytomegalovirus infection.

  1978cited by this paper
• Measles virus and its biology

  1978cited by this paper
• FAST TRACK: A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome

  year unknowncited by this paper

• From Biocompatibility to Immune Engineering

  2016cites this paper
• From Biocompatibility to Immune Engineering.

  2016cites this paper
• Therapeutic Antibody Agents for B-Cell Immunomodulation in Renal Transplantation

  2007cites this paper